Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis
Ravi Mahadeva, Wun-Shaing W. Chang, Timothy R. Dafforn, Diana J. Oakley, Richard C. Foreman, Jacqueline Calvin, Derek G.D. Wight, David A. Lomas
Ravi Mahadeva, Wun-Shaing W. Chang, Timothy R. Dafforn, Diana J. Oakley, Richard C. Foreman, Jacqueline Calvin, Derek G.D. Wight, David A. Lomas
View: Text | PDF
Article

Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis

  • Text
  • PDF
Abstract

The association between Z α1-antitrypsin deficiency and juvenile cirrhosis is well-recognized, and there is now convincing evidence that the hepatic inclusions are the result of entangled polymers of mutant Z α1-antitrypsin. Four percent of the northern European Caucasian population are heterozygotes for the Z variant, but even more common is S α1-antitrypsin, which is found in up to 28% of southern Europeans. The S variant is known to have an increased susceptibility to polymerization, although this is marginal compared with the more conformationally unstable Z variant. There has been speculation that the two may interact to produce cirrhosis, but this has never been demonstrated experimentally. This hypothesis was raised again by the observation reported here of a mixed heterozygote for Z α1-antitrypsin and another conformationally unstable variant (I α1-antitrypsin; 39Arg→Cys) identified in a 34-year-old man with cirrhosis related to α1-antitrypsin deficiency. The conformational stability of the I variant has been characterized, and we have used fluorescence resonance energy transfer to demonstrate the formation of heteropolymers between S and Z α1-antitrypsin. Taken together, these results indicate that not only may mixed variants form heteropolymers, but that this can causally lead to the development of cirrhosis.

Authors

Ravi Mahadeva, Wun-Shaing W. Chang, Timothy R. Dafforn, Diana J. Oakley, Richard C. Foreman, Jacqueline Calvin, Derek G.D. Wight, David A. Lomas

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
(a) Nondenaturing PAGE (7.5-15% wt/vol) showing that a mixture of IZ α1-...
(a) Nondenaturing PAGE (7.5-15% wt/vol) showing that a mixture of IZ α1-antitrypsin loses protein from the monomeric band and forms high molecular mass polymers more readily than I α1-antitrypsin alone. The proteins were incubated at 2 mg/ml and 41°C in 50 mM Tris, 50 mM KCl (pH 7.4). All lanes contain 10 μg protein. Top: I α1-antitrypsin; bottom: IZ α1-antitrypsin. Lane 1, time 0; lane 2, 1 day; lane 3, 2 days; lane 4, 3 days; lane 5, 6 days; lane 6, 12 days. (b) Rate of polymerization of M, I, S, and Z α1-antitrypsin mutants at 0.1 mg/ml and 45°C determined from the measurement of intrinsic tryptophan fluorescence. The values for the rate of polymerization (Table 1) were obtained from fitting the data to Equation 1 and are the weighted mean and standard error of three (I, S, and Z α1-antitrypsin) or four (M α1-antitrypsin) experiments. The rate of polymer formation of mixtures of IZ and MZ α1-antitrypsin were calculated using a 1:1 mixture of the variants at 45°C. The concentration of each variant in the mixture was half that shown in b in order to keep the final protein concentration at 0.1 mg/ml. The curves for each component of the reaction were dissected from the final profile, and the rate of each component in the mixture was obtained by fitting the data to Equation 1. The results shown in Table 2 are the weighted mean and SE of two kinetic experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts